{"id":328506,"date":"2026-10-27T14:43:13","date_gmt":"2026-10-27T09:13:13","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/"},"modified":"2026-10-27T14:43:13","modified_gmt":"2026-10-27T09:13:13","slug":"indoco-remedies-q2-results-fy27-pat-31-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/","title":{"rendered":"Indoco Remedies Q2 Results FY27: PAT Rs 30.63 Cr Against Loss Last Year, Revenue Rs 451.59 Cr"},"content":{"rendered":"<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Indoco Remedies Q2 Results FY27 were declared on 27 October 2026 and show revenue of Rs 451.59 Cr, down 6.83% from Rs 484.67 Cr in the same quarter last year. Net profit came in at Rs 30.63 Cr against a loss of Rs 7.93 Cr a year earlier. These quarterly results pair a lower top line with a profit, and the YoY growth figure for net profit is 486.25% because the base was a loss.<\/p>\n<\/div>\n<p><a href=\"https:\/\/univest.in\/stocks\/indoco\/indoco-remedies-ltd-share-price-today\">Indoco Remedies Ltd<\/a> (INDOCO) Q2 Results FY27 announced on 27 October 2026, covering the company&#8217;s financial performance for the July to September quarter. The results date brought revenue of Rs 451.59 Cr and net profit of Rs 30.63 Cr into view, and Indoco Remedies Q2 Results FY27 set both lines against the same quarter of the previous year. Readers can follow the company on the Univest app.<\/p>\n<p>This results analysis of Indoco Remedies Q2 Results walks through the financial highlights, the business factors behind the numbers, the outlook for FY27 and the risks that investors may want to track. It starts with the Financial Highlights table that follows.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quarterly_results\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#Indoco_Remedies_Q2_Results_FY27_Financial_Highlights\" title=\"Indoco Remedies Q2 Results FY27: Financial Highlights\">Indoco Remedies Q2 Results FY27: Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#Key_Takeaways_from_Indoco_Remedies_Q2_Results_What_Stands_Out\" title=\"Key Takeaways from Indoco Remedies Q2 Results: What Stands Out\">Key Takeaways from Indoco Remedies Q2 Results: What Stands Out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#Indoco_Remedies_Q2_Results_FY27_Performance_Analysis\" title=\"Indoco Remedies Q2 Results FY27: Performance Analysis\">Indoco Remedies Q2 Results FY27: Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#Key_Business_Factors_This_Quarter\" title=\"Key Business Factors This Quarter\">Key Business Factors This Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#FY27_Outlook_After_Indoco_Remedies_Q2_Results\" title=\"FY27 Outlook After Indoco Remedies Q2 Results\">FY27 Outlook After Indoco Remedies Q2 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#Key_Risks_to_Watch_After_Indoco_Remedies_Q2_Results_FY27\" title=\"Key Risks to Watch After Indoco Remedies Q2 Results FY27\">Key Risks to Watch After Indoco Remedies Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#Revenue_Decline\" title=\"Revenue Decline\">Revenue Decline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#Low_Returns_on_Equity_and_Capital\" title=\"Low Returns on Equity and Capital\">Low Returns on Equity and Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#High_Debt_Level\" title=\"High Debt Level\">High Debt Level<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#Frequently_Asked_Questions_on_Indoco_Remedies_Q2_Results_FY27\" title=\"Frequently Asked Questions on Indoco Remedies Q2 Results FY27\">Frequently Asked Questions on Indoco Remedies Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#What_are_Indoco_Remedies_Q2_Results_FY27\" title=\"What are Indoco Remedies Q2 Results FY27?\">What are Indoco Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#What_is_the_results_date_for_Indoco_Remedies_Q2_Results_FY27\" title=\"What is the results date for Indoco Remedies Q2 Results FY27?\">What is the results date for Indoco Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#What_revenue_was_reported_in_Indoco_Remedies_Q2_Results_FY27\" title=\"What revenue was reported in Indoco Remedies Q2 Results FY27?\">What revenue was reported in Indoco Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#What_net_profit_was_reported_in_Indoco_Remedies_Q2_Results_FY27\" title=\"What net profit was reported in Indoco Remedies Q2 Results FY27?\">What net profit was reported in Indoco Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#How_much_YoY_growth_did_revenue_show_in_Indoco_Remedies_Q2_Results_FY27\" title=\"How much YoY growth did revenue show in Indoco Remedies Q2 Results FY27?\">How much YoY growth did revenue show in Indoco Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#Did_net_profit_rise_or_fall_in_Indoco_Remedies_Q2_Results\" title=\"Did net profit rise or fall in Indoco Remedies Q2 Results?\">Did net profit rise or fall in Indoco Remedies Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#What_was_the_net_profit_margin_in_Indoco_Remedies_Q2_Results_FY27\" title=\"What was the net profit margin in Indoco Remedies Q2 Results FY27?\">What was the net profit margin in Indoco Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#What_were_the_return_ratios_after_Indoco_Remedies_Q2_Results\" title=\"What were the return ratios after Indoco Remedies Q2 Results?\">What were the return ratios after Indoco Remedies Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#What_business_factors_shaped_Indoco_Remedies_Q2_Results_FY27\" title=\"What business factors shaped Indoco Remedies Q2 Results FY27?\">What business factors shaped Indoco Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#What_are_the_key_risks_after_Indoco_Remedies_Q2_Results_FY27\" title=\"What are the key risks after Indoco Remedies Q2 Results FY27?\">What are the key risks after Indoco Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#What_is_the_outlook_after_Indoco_Remedies_Q2_Results\" title=\"What is the outlook after Indoco Remedies Q2 Results?\">What is the outlook after Indoco Remedies Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/indoco-remedies-q2-results-fy27-pat-31-crore\/#Where_can_I_find_the_complete_Indoco_Remedies_Q2_Results_FY27_data\" title=\"Where can I find the complete Indoco Remedies Q2 Results FY27 data?\">Where can I find the complete Indoco Remedies Q2 Results FY27 data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Indoco_Remedies_Q2_Results_FY27_Financial_Highlights\"><\/span><strong>Indoco Remedies Q2 Results FY27: Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q2 FY27 (Sep 26)<\/th>\n<th>Q2 FY26 (Sep 25)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 451.59 Cr<\/td>\n<td>Rs 484.67 Cr<\/td>\n<td>-6.83% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT)<\/strong><\/td>\n<td>Rs 30.63 Cr<\/td>\n<td>Rs -7.93 Cr<\/td>\n<td>+486.25% YoY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source: company filing for Indoco Remedies Q2 Results FY27, 27 October 2026. Figures in Rs Crore.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_Indoco_Remedies_Q2_Results_What_Stands_Out\"><\/span><strong>Key Takeaways from Indoco Remedies Q2 Results: What Stands Out<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Revenue fell 6.83% YoY<\/strong> to Rs 451.59 Cr from Rs 484.67 Cr in the same quarter last year, a decline of Rs 33.08 Cr in absolute terms.<\/li>\n<li><strong>Net profit reached Rs 30.63 Cr<\/strong> against a net loss of Rs 7.93 Cr a year earlier, which gives YoY growth of 486.25% on a negative base.<\/li>\n<li><strong>Net profit margin rose to 6.8%<\/strong> from -1.6% in the comparison quarter, so Indoco Remedies Q2 Results FY27 combine lower revenue with a higher margin.<\/li>\n<li><strong>Return on capital employed was 0.79% in FY26<\/strong> against -0.43% in FY25, while return on equity was -10.13% in FY26.<\/li>\n<li><strong>The performance analysis comes next<\/strong>, where the revenue move and the net profit move are read together for the quarter.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Indoco_Remedies_Q2_Results_FY27_Performance_Analysis\"><\/span><strong>Indoco Remedies Q2 Results FY27: Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Indoco Remedies Q2 Results show revenue of Rs 451.59 Cr for the July to September 2026 quarter, down 6.83% YoY from Rs 484.67 Cr, while net profit was Rs 30.63 Cr against a loss of Rs 7.93 Cr a year earlier. Revenue and net profit therefore moved in opposite directions on a YoY basis.<\/p>\n<p>Indoco Remedies Q2 Results FY27 show a Rs 33.08 Cr fall in revenue alongside a Rs 38.56 Cr rise in net profit, since the loss of Rs 7.93 Cr became a profit of Rs 30.63 Cr. This results analysis treats the 486.25% YoY growth in net profit as a move from a negative base, which makes the percentage large.<\/p>\n<p>Looking at Indoco Remedies Q2 Results FY27 through margins, the net profit margin of 6.8% compares with -1.6% in the comparison quarter. The data confirms what changed but does not establish the specific cause, so the quarterly results are read next through the disclosed business factors, which is where the business factors take over.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live results data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_This_Quarter\"><\/span><strong>Key Business Factors This Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Return to Net Profit<\/strong> &#8211; The business factors behind these quarterly results start with the swing in net profit, as the company returned to a net profit of Rs 30.63 Cr from a loss in the comparison quarter. In Indoco Remedies Q2 Results FY27, this swing is the largest single change in the numbers.<\/p>\n<p><strong>Net Profit Margin<\/strong> &#8211; Net profit margin improved to 6.8% from -1.6% in the comparison quarter. This margin shift took place while revenue declined 6.83% YoY, so the improvement reflects profit relative to revenue and not higher sales.<\/p>\n<p><strong>Return on Capital Employed<\/strong> &#8211; Return on capital employed improved to 0.79% in FY26 from -0.43% in FY25. This is a full-year measure, so it describes FY26 and not the July to September quarter, and it sits alongside the quarterly figures.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_After_Indoco_Remedies_Q2_Results\"><\/span><strong>FY27 Outlook After Indoco Remedies Q2 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The FY27 outlook depends on the quarters still to be reported. Indoco Remedies Q2 Results FY27 cover a single quarter, and the full-year results will depend on subsequent quarters and disclosed sector conditions rather than on this filing alone.<\/p>\n<p>A results analysis for the rest of FY27 can track whether net profit stays near Rs 30.63 Cr or moves with revenue, which fell 6.83% YoY this quarter. Investors can follow each new filing in the Univest app, and the figures also bring a set of risks that come next.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_Indoco_Remedies_Q2_Results_FY27\"><\/span><strong>Key Risks to Watch After Indoco Remedies Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Decline\"><\/span><strong>Revenue Decline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Revenue declined 6.8% year on year to Rs 451.59 Cr in the latest quarter. Net profit rose while revenue fell, and Indoco Remedies Q2 Results FY27 leave the revenue trend as the first item to monitor in later YoY growth comparisons.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Low_Returns_on_Equity_and_Capital\"><\/span><strong>Low Returns on Equity and Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on equity was low at -10.13% in FY26, and return on capital employed was modest at 0.79% in FY26. Both are full-year ratios and they sit beside the quarter&#8217;s net profit of Rs 30.63 Cr.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"High_Debt_Level\"><\/span><strong>High Debt Level<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Debt is high at 1.11 times total assets in FY26. A debt level above total assets is a balance sheet fact that investors may weigh alongside the quarter&#8217;s profit and the 6.83% revenue decline.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track quarterly results as they are declared.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Indoco Remedies Q2 Results FY27 record revenue of Rs 451.59 Cr, down 6.83% YoY, and net profit of Rs 30.63 Cr against a loss a year earlier. The quarterly results therefore pair lower sales with a profit. Indoco Remedies Q2 Results are best read with the risks above and the Univest Screener, and investors should consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Indoco_Remedies_Q2_Results_FY27\"><\/span><strong>Frequently Asked Questions on Indoco Remedies Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_Indoco_Remedies_Q2_Results_FY27\"><\/span><strong>What are Indoco Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Indoco Remedies Q2 Results FY27 cover the July to September 2026 quarter, with revenue of Rs 451.59 Cr and net profit of Rs 30.63 Cr, while the Quick Answer box at the top of the article summarises both figures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_results_date_for_Indoco_Remedies_Q2_Results_FY27\"><\/span><strong>What is the results date for Indoco Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Indoco Remedies declared its Q2 FY27 numbers on 27 October 2026, which is the results date for the quarter, so the opening paragraphs place revenue and net profit against that date.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_revenue_was_reported_in_Indoco_Remedies_Q2_Results_FY27\"><\/span><strong>What revenue was reported in Indoco Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Indoco Remedies reported revenue of Rs 451.59 Cr in Q2 FY27, compared with Rs 484.67 Cr a year earlier, which means revenue fell by Rs 33.08 Cr, as the Financial Highlights table shows.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_net_profit_was_reported_in_Indoco_Remedies_Q2_Results_FY27\"><\/span><strong>What net profit was reported in Indoco Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Indoco Remedies reported net profit of Rs 30.63 Cr in Q2 FY27 against a loss of Rs 7.93 Cr a year earlier, so net profit moved by Rs 38.56 Cr, as the Performance Analysis explains.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_YoY_growth_did_revenue_show_in_Indoco_Remedies_Q2_Results_FY27\"><\/span><strong>How much YoY growth did revenue show in Indoco Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Indoco Remedies revenue changed by -6.83% YoY in Q2 FY27, so it declined rather than grew, while net profit moved from a loss to Rs 30.63 Cr, as the Key Takeaways section notes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_net_profit_rise_or_fall_in_Indoco_Remedies_Q2_Results\"><\/span><strong>Did net profit rise or fall in Indoco Remedies Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit rose to Rs 30.63 Cr from a loss of Rs 7.93 Cr, a YoY growth figure of 486.25%, which means the percentage reflects a move from a negative base, as the Performance Analysis explains.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_net_profit_margin_in_Indoco_Remedies_Q2_Results_FY27\"><\/span><strong>What was the net profit margin in Indoco Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Indoco Remedies posted a net profit margin of 6.8% in Q2 FY27, up from -1.6% in the comparison quarter, so profit relative to revenue rose even as revenue declined, as the Key Business Factors section describes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_the_return_ratios_after_Indoco_Remedies_Q2_Results\"><\/span><strong>What were the return ratios after Indoco Remedies Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Return on capital employed was 0.79% in FY26 against -0.43% in FY25, while return on equity was -10.13% in FY26, so both full-year ratios are also covered in the Key Risks section.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_business_factors_shaped_Indoco_Remedies_Q2_Results_FY27\"><\/span><strong>What business factors shaped Indoco Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The business factors are the return to a net profit of Rs 30.63 Cr, the net profit margin of 6.8% and the higher return on capital employed, which the Key Business Factors section explains in turn.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_after_Indoco_Remedies_Q2_Results_FY27\"><\/span><strong>What are the key risks after Indoco Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The risks are the 6.83% YoY revenue decline, return on equity of -10.13% and debt at 1.11 times total assets in FY26, so the Key Risks section covers each of them in turn.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_after_Indoco_Remedies_Q2_Results\"><\/span><strong>What is the outlook after Indoco Remedies Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The FY27 outlook depends on the quarters still to be reported, because full-year results will follow subsequent quarters and disclosed sector conditions, which is why the FY27 Outlook section avoids any forecast.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_find_the_complete_Indoco_Remedies_Q2_Results_FY27_data\"><\/span><strong>Where can I find the complete Indoco Remedies Q2 Results FY27 data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The complete figures sit in the Financial Highlights table of this article, while the Univest Screener lets you open the Indoco Remedies stock page for further details on the company.<\/p>\n<p><script type=\"application\/ld+json\" class=\"faq-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are Indoco Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Indoco Remedies Q2 Results FY27 cover the July to September 2026 quarter, with revenue of Rs 451.59 Cr and net profit of Rs 30.63 Cr, while the Quick Answer box at the top of the article summarises both figures.\"}},{\"@type\":\"Question\",\"name\":\"What is the results date for Indoco Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Indoco Remedies declared its Q2 FY27 numbers on 27 October 2026, which is the results date for the quarter, so the opening paragraphs place revenue and net profit against that date.\"}},{\"@type\":\"Question\",\"name\":\"What revenue was reported in Indoco Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Indoco Remedies reported revenue of Rs 451.59 Cr in Q2 FY27, compared with Rs 484.67 Cr a year earlier, which means revenue fell by Rs 33.08 Cr, as the Financial Highlights table shows.\"}},{\"@type\":\"Question\",\"name\":\"What net profit was reported in Indoco Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Indoco Remedies reported net profit of Rs 30.63 Cr in Q2 FY27 against a loss of Rs 7.93 Cr a year earlier, so net profit moved by Rs 38.56 Cr, as the Performance Analysis explains.\"}},{\"@type\":\"Question\",\"name\":\"How much YoY growth did revenue show in Indoco Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Indoco Remedies revenue changed by -6.83% YoY in Q2 FY27, so it declined rather than grew, while net profit moved from a loss to Rs 30.63 Cr, as the Key Takeaways section notes.\"}},{\"@type\":\"Question\",\"name\":\"Did net profit rise or fall in Indoco Remedies Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit rose to Rs 30.63 Cr from a loss of Rs 7.93 Cr, a YoY growth figure of 486.25%, which means the percentage reflects a move from a negative base, as the Performance Analysis explains.\"}},{\"@type\":\"Question\",\"name\":\"What was the net profit margin in Indoco Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Indoco Remedies posted a net profit margin of 6.8% in Q2 FY27, up from -1.6% in the comparison quarter, so profit relative to revenue rose even as revenue declined, as the Key Business Factors section describes.\"}},{\"@type\":\"Question\",\"name\":\"What were the return ratios after Indoco Remedies Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Return on capital employed was 0.79% in FY26 against -0.43% in FY25, while return on equity was -10.13% in FY26, so both full-year ratios are also covered in the Key Risks section.\"}},{\"@type\":\"Question\",\"name\":\"What business factors shaped Indoco Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The business factors are the return to a net profit of Rs 30.63 Cr, the net profit margin of 6.8% and the higher return on capital employed, which the Key Business Factors section explains in turn.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks after Indoco Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The risks are the 6.83% YoY revenue decline, return on equity of -10.13% and debt at 1.11 times total assets in FY26, so the Key Risks section covers each of them in turn.\"}},{\"@type\":\"Question\",\"name\":\"What is the outlook after Indoco Remedies Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The FY27 outlook depends on the quarters still to be reported, because full-year results will follow subsequent quarters and disclosed sector conditions, which is why the FY27 Outlook section avoids any forecast.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find the complete Indoco Remedies Q2 Results FY27 data?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The complete figures sit in the Financial Highlights table of this article, while the Univest Screener lets you open the Indoco Remedies stock page for further details on the company.\"}}]}<\/script><br \/>\n<script type=\"application\/ld+json\" class=\"news-article-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Indoco Remedies Q2 Results FY27: PAT Rs 30.63 Cr Against Loss Last Year, Revenue Rs 451.59 Cr\",\"description\":\"Indoco Remedies Q2 Results: revenue \u20b9451.59 Cr, PAT \u20b930.63 Cr. Check YoY growth and quarterly results analysis from the 27 October 2026 filing.\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"Indoco Remedies Ltd\"}}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Indoco Remedies Q2 Results FY27: revenue Rs 451.59 Cr, down 6.83% YoY, and net profit Rs 30.63 Cr against a loss a year earlier.<\/p>\n","protected":false},"author":29,"featured_media":328505,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-328506","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["328505"],"rank_math_title":["Indoco Remedies Q2 Results FY27: PAT Rs 30.63 Cr Against Loss"],"rank_math_description":["Indoco Remedies Q2 Results: revenue \u20b9451.59 Cr, PAT \u20b930.63 Cr. Check YoY growth and quarterly results analysis from the 27 October 2026 filing."],"rank_math_focus_keyword":["Indoco Remedies Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/indoco-remedies-q2-results-fy27-pat-rs-30-63-cr-against-loss-last-year-revenue.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/328506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=328506"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/328506\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/328505"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=328506"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=328506"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=328506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}